Key Finding
Acupuncture significantly outperformed oral medication for IBS-D with comorbid anxiety and depression, reducing relapse rates by 73% while improving both gastrointestinal and psychological symptoms.
Researchers analyzed 16 studies involving 1,305 patients to determine whether acupuncture can help people with diarrhea-predominant irritable bowel syndrome (IBS-D) who also experience anxiety and depression. IBS-D causes frequent diarrhea, abdominal pain, and bowel discomfort, and many patients simultaneously struggle with mental health symptoms that complicate their treatment.
The research team examined data from Chinese and international medical databases, comparing acupuncture treatment to standard oral medications. They measured improvements in anxiety scores, depression scores, IBS symptom severity, treatment response rates, and relapse rates.
The findings were compelling: acupuncture significantly improved both anxiety and depression symptoms compared to medication alone. Patients receiving acupuncture showed better scores on standardized anxiety assessments (HAMA and self-rating anxiety scales) and depression measures (HAMD and SDS). Additionally, acupuncture reduced overall IBS symptom severity and achieved higher treatment response rates. Perhaps most importantly, patients who received acupuncture experienced substantially lower relapse rates, meaning their symptoms were less likely to return after treatment ended.
For patients suffering from IBS-D with anxiety and depression, these results suggest acupuncture offers a valuable treatment option with meaningful benefits beyond conventional medication. The therapy appears to address both the digestive symptoms and the emotional challenges simultaneously, without the adverse effects commonly associated with pharmaceutical interventions. The lower relapse rates also indicate that acupuncture may provide more durable improvements.
If you're considering acupuncture for IBS-D with anxiety or depression, consult with a licensed acupuncturist who has experience treating gastrointestinal and mental health conditions.
This meta-analysis evaluated 16 RCTs (n=1,305; 691 experimental, 614 control) examining acupuncture efficacy for IBS-D with comorbid anxiety and depression. Studies were sourced from seven databases through August 2023, with data analyzed using RevMan 5.4 and Stata 17.0.
Compared to oral medication, acupuncture demonstrated statistically significant improvements across multiple validated measures: HAMD scores (MD=0.88, 95% CI [0.68, 1.07], P<0.00001), HAMA scores (MD=2.32, 95% CI [1.70, 2.93], P<0.00001), SAS scores (MD=11.67, 95% CI [10.85, 12.49], P<0.00001), and SDS scores (MD=9.84, 95% CI [8.52, 11.16], P<0.00001). IBS-SSS scores improved significantly (MD=37.48, 95% CI [12.17, 62.78], P=0.004), with superior overall response rates (MD=1.27, 95% CI [1.20, 1.35], P<0.00001) and dramatically reduced relapse rates (MD=0.27, 95% CI [0.16, 0.47], P<0.00001).
Clinical implications: Acupuncture offers robust therapeutic benefit for IBS-D patients with psychiatric comorbidity, addressing both gastrointestinal and psychological symptoms with sustained effects and lower recurrence risk than pharmacotherapy alone.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Manual acupuncture significantly reduced anxiety symptoms post-treatment compared to both sham acupuncture and usual care, with effects sustained at follow-up versus sham acupuncture but not usual care.
📌 This is a systematic review protocol outlining plans to evaluate MSRT's effects on anxiety, sleep quality, and quality of life in adults, but does not yet contain actual findings from completed research.
📌 Acupuncture combined with SSRI/SNRI medications significantly reduced anxiety scores in somatic symptom disorder patients at 4 weeks compared to medication alone, though evidence quality was low and pain outcomes showed no significant benefit.